298 related articles for article (PubMed ID: 36044375)
21. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
Viruses; 2020 May; 12(5):. PubMed ID: 32443728
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stromal Cells: a Possible Reservoir for HIV-1?
Kallmeyer K; Ryder MA; Pepper MS
Stem Cell Rev Rep; 2022 Apr; 18(4):1253-1280. PubMed ID: 34973144
[TBL] [Abstract][Full Text] [Related]
23. The Brain Retains: Nonhuman Primate Models for Pediatric HIV-1 in the CNS.
Obregon-Perko V; Bricker K; Chahroudi A
Curr HIV/AIDS Rep; 2020 Aug; 17(4):343-353. PubMed ID: 32388691
[TBL] [Abstract][Full Text] [Related]
24. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
[TBL] [Abstract][Full Text] [Related]
25. Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDS.
Swanstrom AE; Jacques A; Del Prete GQ; Bieniasz P; Hatziioannou T; Gorelick R; Lifson JD
AIDS Res Hum Retroviruses; 2019 May; 35(5):473-476. PubMed ID: 30632394
[TBL] [Abstract][Full Text] [Related]
26. HIV Persistence in Adipose Tissue Reservoirs.
Couturier J; Lewis DE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
[TBL] [Abstract][Full Text] [Related]
27. SIV Latency in Macrophages in the CNS.
Gama L; Abreu C; Shirk EN; Queen SE; Beck SE; Metcalf Pate KA; Bullock BT; Zink MC; Mankowski JL; Clements JE
Curr Top Microbiol Immunol; 2018; 417():111-130. PubMed ID: 29770863
[TBL] [Abstract][Full Text] [Related]
28. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
[TBL] [Abstract][Full Text] [Related]
29. Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era.
León-Rivera R; Veenstra M; Donoso M; Tell E; Eugenin EA; Morgello S; Berman JW
mBio; 2021 Mar; 12(2):. PubMed ID: 33727362
[TBL] [Abstract][Full Text] [Related]
30. The HIV Reservoir in Monocytes and Macrophages.
Wong ME; Jaworowski A; Hearps AC
Front Immunol; 2019; 10():1435. PubMed ID: 31297114
[TBL] [Abstract][Full Text] [Related]
31. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
[TBL] [Abstract][Full Text] [Related]
32. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy.
Schwarzer R; Gramatica A; Greene WC
Viruses; 2020 Feb; 12(2):. PubMed ID: 32046251
[TBL] [Abstract][Full Text] [Related]
33. A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.
Clements JE; Gama L; Graham DR; Mankowski JL; Zink MC
Curr Opin HIV AIDS; 2011 Jan; 6(1):37-42. PubMed ID: 21242892
[TBL] [Abstract][Full Text] [Related]
34. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.
Perez S; Johnson AM; Xiang SH; Li J; Foley BT; Doyle-Meyers L; Panganiban A; Kaur A; Veazey RS; Wu Y; Ling B
J Neurovirol; 2018 Feb; 24(1):62-74. PubMed ID: 29181724
[TBL] [Abstract][Full Text] [Related]
35. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
36. Specific Activation
Li G; Zhang Z; Reszka-Blanco N; Li F; Chi L; Ma J; Jeffrey J; Cheng L; Su L
J Virol; 2019 Jun; 93(12):. PubMed ID: 30971469
[TBL] [Abstract][Full Text] [Related]
37. Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies.
Del Prete GQ; Lifson JD
Curr Opin HIV AIDS; 2013 Jul; 8(4):262-72. PubMed ID: 23698559
[TBL] [Abstract][Full Text] [Related]
38. Potent
Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
[TBL] [Abstract][Full Text] [Related]
39. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.
Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E
Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
